Page 2 - சீன குழந்தைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

International collaboration aims to develop better therapy for childhood acute lymphoblastic leukemia Scientists at St. Jude Children s Research Hospital are working with colleagues in China to develop better therapy for childhood acute lymphoblastic leukemia (ALL). Results from a large phase 3 noninferiority clinical trial definitively showed that vincristine and dexamethasone pulses can be eliminated in patients with low-risk disease. The findings were published today in The Lancet Oncology. Adding the chemotherapy vincristine plus a steroid (originally prednisone, and later dexamethasone) as pulse therapy for childhood ALL has been part of standard care since the 1970s. This is despite their being associated with neuropsychological side effects, neuropathy and other late effects. However, to date studies about the need for prolonged treatment with pulse therapy have been inconclusive.

Emily hendersonJude children research hospitalChinese children cancer groupJude department of oncologyJude childrenResearch hospitalChing hon puiJude departmentChinese childrenCancer groupஎமிலி ஹென்டர்சன்ஜூட் குழந்தைகள் ஆராய்ச்சி மருத்துவமனைசீன குழந்தைகள் புற்றுநோய் குழுஜூட் துறை ஆஃப் புற்றுநோயியல்ஜூட் குழந்தைகள்ஆராய்ச்சி மருத்துவமனை